Eligibility Matcher

Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.

500 grants for State governments

Sorted by deadline (soonest first)

DOT-FTA · FTA-2026-011-TPM-LWNO

USDOJ-OJP-BJA · O-BJA-2026-172675

USDOJ-OJP-BJA · O-BJA-2026-172679

USDOJ-OJP-BJA · O-BJA-2026-172674

HHS-NIH11 · RFA-AI-27-004

USDOJ-OJP-BJA · O-BJA-2026-172673

USDOJ-OJP-BJA · O-BJA-2026-172698

USDOJ-OJP-BJA · O-BJA-2026-172700

USDOJ-OJP-BJA · O-BJA-2026-172701

USDOJ-OJP-BJA · O-BJA-2026-172702

HHS-NIH11 · PAR-23-228

HHS-NIH11 · PAR-25-247

HHS-NIH11 · PAR-23-284

HHS-NIH11 · PAR-24-065

HHS-NIH11 · PAR-24-071

HHS-NIH11 · PAR-24-259

HHS-NIH11 · PAR-24-167

HHS-NIH11 · RFA-CA-27-012

DOI-BLM · L26AS00057

DOI-FWS · F27AS00008

USDOJ-OJP-OVW · O-OVW-2026-172670

USDOJ-OJP-BJA · O-BJA-2026-172677

USDOJ-OJP-BJA · O-BJA-2026-172676

HHS-NIH11 · RFA-CA-24-026

HHS-NIH11 · RFA-NS-25-022

Eligibility Matcher

500 grants for State governments

Fiscal Year 2026 Competitive Funding Opportunity: Low or No Emission Program

BJA FY 2026 Harold Rogers Prescription Drug Monitoring Program

BJA FY 2026 Intellectual Property Enforcement Program: Protecting Public Health, Safety, and the Economy from Counterfeit Goods and Product Piracy

BJA FY26 Investigating and Prosecuting Sexual Assaults in Confinement Facilities Program

Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)

BJA FY 2026 Smart Reentry Demonstration Program

BJA FY 2026 Second Chance Act Improving Reentry Education and Employment Outcomes

BJA FY 2026 Second Chance Act Family-Based Substance Use Disorder Treatment Program

BJA FY 2026 Local Law Enforcement Crime Gun Intelligence Center Integration Initiative

BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program

National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)

Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)

NHLBI Program Project Applications (P01 Clinical Trials Optional)

Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)

Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (S15 Clinical Trial Not Allowed)

Utilizing Equipment to Study Environmental Extrinsic Factors and Enhance Rigor and Reproducibility of Animal Research (R24, Clinical Trials Not-Allowed)

Metastasis Research Network (U54 Clinical Trial Not Allowed)

FY26 Bureau of Land Management Invasive and Noxious Plant Management - Bureau wide

F27AS00008-NAWCA 2027-1 US Standard Grants

OVW Fiscal Year 2026 Training and Services to End Violence and Abuse Against Individuals with Disabilities and Deaf People Program

BJA FY26 Body-Worn Camera Policy and Implementation Program to Support Law Enforcement Agencies

BJA FY 2026 Public Safety and Mental Health Initiative

National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)